UK NSC stakeholder engagement strategy
Guidance that explains how the UK National Screening Committee (UK NSC) engages with its stakeholders.
Documents
Details
The UK National Screening Committee (UK NSC) stakeholder engagement strategy for 2022 to 2024 outlines how the UK NSC plans to review and build on its ongoing engagement with stakeholders. It supports the following recommendation made by the 4 UK chief medical officers (CMOs) for the expanded remit of the UK NSC following the independent review of adult screening programmes in England:
The secretariat for the UK NSC should continue with its efforts to improve stakeholder engagement and consider whether additional/different engagement will be needed for decisions made around targeted and stratified screening.
Commercial engagement with the UK NSC describes how the UK NSC can exchange ideas and knowledge with commercial organisations.
Email [email protected] if you have any queries about this publication, making sure you include its full title.
Updates to this page
Published 29 September 2022Last updated 15 September 2023 + show all updates
-
Stakeholder strategy and commercial engagement guidance made into separate publications.
-
Addition of deadline for applications to attend multi-cancer early detection tests information sharing event
-
Announcement of commercial roundtable event on 21 February to discuss multi-cancer early detection tests.
-
Publication of additional guidance on how the UK NSC engages and exchanges ideas with commercial organisations.
-
First published.